Nimrah Bader

PS-052-End of study results from LIMT HDV study: 36% durable virologic response at 24 weeks post-treatment with pegylated interferon lambda monotherapy in patients with chronic hepatitis delta virus infection

Ohad Etzion, Saeed Hamid, Yoav Lurie et al. · Journal of Hepatology · 2019 · 53 citations

Viral Persistence, Hepatology, Viral Hepatitis +10

Comparison of Vonoprazan and Amoxicillin Dual Therapy with Standard Triple Therapy with Proton Pump Inhibitor for Helicobacter Pylori eradication: A Randomized Control Trial

Bader Faiyaz Zuberi, Faiza Sadaqat Ali, Tazeen Rasheed et al. · Pakistan Journal of Medical Sciences · 2022 · 47 citations · Full text

Treatment of chronic hepatitis D with peginterferon lambda—the phase 2 LIMT-1 clinical trial

Ohad Etzion, Saeed Hamid, Yoav Lurie et al. · Hepatology · 2023 · 40 citations · Full text

Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin

Nimrah Bader, Lubna Mirza · Pakistan Journal of Medical Sciences · 2016 · 27 citations · Full text

Metabolic Syndrome, Type 1, Diabetes Management +13

Role of multifunctional Chemerin in obesity and preclinical diabetes

Syeda Sadia Fatima, Zoya Butt, Nimrah Bader et al. · Obesity Research & Clinical Practice · 2015 · 24 citations

Obesity, Metabolic Syndrome, Biochemistry +7